** Medical equipment maker Haemonetics' HAE.N shares fall 8.3% to $65.3 to touch an over 2-1/2 year low
** Co cuts its sales growth forecast for fiscal 2025 to 3%-5% from 5%-8%
** Co reports Q3 revenue of $349 million, missing analyst estimates of $353 million - data compiled by LSEG
** Co posts adj Q3 profit of $1.19 per share, beating analyst estimates of $1.17 per share - LSEG
** Shares are down ~17% in the past 12 months
(Reporting by Padmanabhan Ananthan)
((Padmanabhan.Ananthan@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.